P3‐184: Modulation of nitrergic pathway by sesamol prevents cognitive deficits and associated biochemical alterations in intracerebroventricular streptozotocin‐administered rats

No abstract is available for this paper.

• Publication year

  2011

• Venue

  European Journal of Pharmacology

• Publication date

  2011-06-01

• Fields of study

  Medicine, Chemistry, Psychology

• Identifiers
  DOI 10.1016/j.jalz.2011.05.1625PMID 21463622
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy.

  2010cited by this paper
• Protective effect of sesamol on the pulmonary inflammatory response and lung injury in endotoxemic rats.

  2010cited by this paper
• Effects of the nitric oxide synthase inhibitor L-NAME on different memory components as assessed in the object recognition task in the rat.

  2010cited by this paper
• Suppression of neuro-inflammatory signaling cascade by tocotrienol can prevent chronic alcohol-induced cognitive dysfunction in rats.

  2009cited by this paper
• Involvement of nitric oxide in insulin induced memory improvement.

  2008cited by this paper
• Effect of sesamol on diabetes-associated cognitive decline in rats

  2008influential reference
• Nitric oxide signaling pathway in the anti-convulsant effect of adenosine against pentylenetetrazol-induced seizure threshold in mice.

  2008cited by this paper
• Central insulin resistance as a trigger for sporadic Alzheimer-like pathology: an experimental approach.

  2007cited by this paper
• Common pathological processes in Alzheimer disease and type 2 diabetes: a review.

  2007cited by this paper
• Brain insulin system dysfunction in streptozotocin intracerebroventricularly treated rats generates hyperphosphorylated tau protein

  2007cited by this paper
• Evidence for a role for the group I metabotropic glutamate receptor in the inhibitory effect of tumor necrosis factor-alpha on long-term potentiation.

  2007cited by this paper
• Possible involvement of L-arginine-nitric oxide (NO)-cyclic guanosine monophosphate (cGMP) signaling pathway in the antidepressant activity of berberine chloride.

  2007cited by this paper
• SESAMOL DELAYS MORTALITY AND ATTENUATES HEPATIC INJURY AFTER CECAL LIGATION AND PUNCTURE IN RATS: ROLE OF OXIDATIVE STRESS

  2006cited by this paper
• Effect of melatonin and vitamin E on diabetes-induced learning and memory impairment in rats.

  2006cited by this paper
• Development and evaluation of sesamol as an antiaging agent

  2006cited by this paper
• Memantine for dementia.

  2006cited by this paper
• Protective effect of 1,2,4-benzenetriol on LPS-induced NO production by BV2 microglial cells.

  2006cited by this paper
• Photoprotective effect of sesamol on UVB-radiation induced oxidative stress in human blood lymphocytes in vitro.

  2005cited by this paper
• Resveratrol, a polyphenolic phytoalexin protects against cyclosporine-induced nephrotoxicity through nitric oxide dependent mechanism.

  2005cited by this paper
• Ginkgo biloba affords dose‐dependent protection against 6‐hydroxydopamine‐induced parkinsonism in rats: neurobehavioural, neurochemical and immunohistochemical evidences

  2005cited by this paper
• Memantine for dementia.

  2005cited by this paper
• Cholesterol homeostasis in neurons and glial cells.

  2005cited by this paper
• Effect of donepezil and lercanidipine on memory impairment induced by intracerebroventricular streptozotocin in rats.

  2005cited by this paper
• Selenium protects cerebral ischemia in rat brain mitochondria

  2004cited by this paper
• The effect of l-NAME and l-arginine on impairment of memory formation and state-dependent learning induced by morphine in mice

  2003cited by this paper
• Memantine for dementia.

  2003cited by this paper
• Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats.

  2002cited by this paper
• Intracerebroventricular administration of colchicine produces cognitive impairment associated with oxidative stress in rats.

  2002cited by this paper
• Say NO to Alzheimer's disease: the putative links between nitric oxide and dementia of the Alzheimer's type.

  2001cited by this paper
• Effect of chronic treatment of melatonin on learning, memory and oxidative deficiencies induced by intracerebroventricular streptozotocin in rats.

  2001cited by this paper
• Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment.

  2001cited by this paper
• Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study.

  2000cited by this paper
• Nitric oxide synthases: targets for therapeutic strategies in neurological diseases

  1999cited by this paper
• Gender differences in Morris water maze performance depend on task parameters.

  1999cited by this paper
• Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion.

  1999cited by this paper
• Neuronal Nitric Oxide Synthase Activation and Peroxynitrite Formation in Ischemic Stroke Linked to Neural Damage

  1999cited by this paper
• Peroxynitrite‐Induced Alterations in Synaptosomal Membrane Proteins

  1999cited by this paper
• Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release.

  1998cited by this paper
• Amyloid-β peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release

  1998cited by this paper
• Intracerebroventricular administration of streptozotocin causes long-term diminutions in learning and memory abilities and in cerebral energy metabolism in adult rats.

  1998cited by this paper
• A monoclonal antibody against acetylcholinesterase inhibits the formation of amyloid fibrils induced by the enzyme.

  1997cited by this paper
• Synergistic Induction of Nitric Oxide by β-Amyloid and Cytokines in Astrocytes

  1996cited by this paper
• Synergistic induction of nitric oxide by beta-amyloid and cytokines in astrocytes.

  1996cited by this paper
• Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains.

  1996cited by this paper
• Nitric oxide in the nervous system.

  1995cited by this paper
• Inducible nitric oxide synthase and its product nitric oxide, a small molecule with complex biological activities.

  1995cited by this paper
• Reactions of nitric oxide, superoxide and peroxynitrite with superoxide dismutase in neurodegeneration.

  1994cited by this paper
• Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease.

  1994cited by this paper
• Purification of a nitric oxide-stimulated ADP-ribosylated protein using biotinylated beta-nicotinamide adenine dinucleotide.

  1993cited by this paper
• Nerve growth factor and choline acetyltransferase activity levels in the rat brain following experimental impairment of cerebral glucose and energy metabolism

  1992cited by this paper
• Quantitative Development and Molecular Forms of Acetyl‐and Butyrylcholinesterase During Morphogenesis and Synaptogenesis of Chick Brain and Retina

  1987cited by this paper
• Place navigation impaired in rats with hippocampal lesions

  1982cited by this paper
• Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids.

  1982cited by this paper
• Generation of superoxide radical during autoxidation of hydroxylamine and an assay for superoxide dismutase.

  1978cited by this paper
• Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite.

  1974cited by this paper
• Mechanisms of lipid peroxide formation in animal tissues.

  1966cited by this paper
• A new and rapid colorimetric determination of acetylcholinesterase activity.

  1961cited by this paper

• Bioactive Compound‐Fortified Nanocarriers in the Management of Neurodegenerative Disease: A Review

  2025cites this paper
• Investigating the Impact of Intracerebroventricular Streptozotocin on Female Rats with and without Ovaries: Implications for Alzheimer’s Disease

  2024cites this paper
• Anti-viral Effects of Pavetta indica Methanolic Extract and Acyclovir on Behavioral and Biochemical Parameters in Streptozotocin-induced Alzheimer's Disease in Rats.

  2024cites this paper
• Yttrium oxide nanoparticles alleviate cognitive deficits, neuroinflammation, and mitochondrial biogenesis impairment induced by streptozotocin.

  2024cites this paper
• Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ (1-42) and NF-kB expression in experimental model of rats.

  2023cites this paper
• Gelatin/polyethylene glycol-loaded magnesium hydroxide nanocomposite to attenuate acetylcholinesterase, neurotoxicity, and activation of GPR55 protein in rat models of Alzheimer's disease.

  2023cites this paper
• Formulation Strategies for Enhancing Pharmaceutical and Nutraceutical Potential of Sesamol: A Natural Phenolic Bioactive

  2023cites this paper
• Sesamol: A Phenolic Compound of Health Benefits and Therapeutic Promise in Neurodegenerative Diseases.

  2023cites this paper
• Neuroprotective effect of phytoconstituents via nanotechnology for treatment of Alzheimer diseases.

  2022cites this paper
• Gelatin/polyvinyl alcohol loaded magnesium hydroxide nanocomposite attenuates neurotoxicity and oxidative stress in Alzheimer's disease induced rats.

  2022cites this paper
• Novel therapeutic mechanism of action of metformin and its nanoformulation in Alzheimer's disease and role of AKT/ERK/GSK pathway.

  2021influential citation
• Neuroprotective effect of sesamol against aluminum nanoparticle-induced toxicity in rats

  2021cites this paper
• Protective Effects of Sesamol on the Brains of Rats with Focal Cerebral Ischemia-Reperfusion Injury

  2021cites this paper
• Sesamol protects hippocampal CA1 neurons and reduces neuronal infarction in global model of cerebral ischemia in rats

  2020cites this paper
• An appraisal of current pharmacological perspectives of sesamol: A review.

  2020cites this paper
• Anti-Amyloid Aggregation Activity of Black Sesame Pigment: Toward a Novel Alzheimer’s Disease Preventive Agent

  2018cites this paper
• Neuroprotection and cognitive enhancement by treatment with γ-oryzanol in sporadic Alzheimer's disease

  2017cites this paper
• Sesamol attenuates oxidative stress, apoptosis and inflammation in focal cerebral ischemia/reperfusion injury.

  2017cites this paper
• Effects of Nitric Oxide (NO) Modulators on Cognitive Function and Brain Oxidative Stress in Experimental Model of Alzheimer’s Disease in Rats

  2017cites this paper
• A benzothiazole/piperazine derivative with acetylcholinesterase inhibitory activity: Improvement in streptozotocin-induced cognitive deficits in rats

  2017cites this paper
• Autophagy impairment mediated by S-nitrosation of ATG4B leads to neurotoxicity in response to hyperglycemia

  2017cites this paper
• Vitamin D3 attenuates cognitive deficits and neuroinflammatory responses in ICV-STZ induced sporadic Alzheimer’s disease

  2017cites this paper
• Mitochondria and neurodegenerative diseases: the promising role of nanotechnology in targeted drug delivery

  2017cites this paper
• An Insight into Mechanisms underlying Sleep Deprivation Induced Cognitive Dysfunction

  2017cites this paper
• Indoxyl Sulfate Affects Glial Function Increasing Oxidative Stress and Neuroinflammation in Chronic Kidney Disease: Interaction between Astrocytes and Microglia

  2017cites this paper
• Effect of mesenchymal stem cells and galantamine nanoparticles in rat model of Alzheimer's disease.

  2016cites this paper
• Dimethyl fumarate attenuates intracerebroventricular streptozotocin-induced spatial memory impairment and hippocampal neurodegeneration in rats.

  2016cites this paper
• Galantamine-loaded solid–lipid nanoparticles for enhanced brain delivery: preparation, characterization, in vitro and in vivo evaluations

  2016cites this paper
• Protective effects of sesamol and ferulic acid on the formation of endogenous trans-arachidonic acid in hAPP J20 mice

  2015cites this paper
• Nano-antioxidants: An emerging strategy for intervention against neurodegenerative conditions.

  2015cites this paper
• Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer’s Disease (sAD)-Like Pathology

  2015cites this paper
• Brain catalase in the streptozotocin-rat model of sporadic Alzheimer’s disease treated with the iron chelator–monoamine oxidase inhibitor, M30

  2015cites this paper
• Possible role of P-glycoprotein in the neuroprotective mechanism of berberine in intracerebroventricular streptozotocin-induced cognitive dysfunction

  2015cites this paper
• Neuroprotective potential of sesamol and its loaded solid lipid nanoparticles in ICV-STZ-induced cognitive deficits: behavioral and biochemical evidence.

  2015cites this paper
• Hepatoprotective effects of sesamol loaded solid lipid nanoparticles in carbon tetrachloride induced sub‐chronic hepatotoxicity in rats

  2014cites this paper
• The ameliorative effects of sesamol against seizures, cognitive impairment and oxidative stress in the experimental model of epilepsy

  2014cites this paper
• Naringin ameliorates memory deficits in experimental paradigm of Alzheimer's disease by attenuating mitochondrial dysfunction.

  2014cites this paper
• Neurobiological effect of 7-nitroindazole, a neuronal nitric oxide synthase inhibitor, in experimental paradigm of Alzheimer's disease.

  2013cites this paper
• Sesamol induces apoptosis in human platelets via reactive oxygen species-mediated mitochondrial damage.

  2013cites this paper
• Effect of sesamol on the pathophysiological changes induced by surgical menopause in rodents

  2013cites this paper
• Sesamol and naringenin reverse the effect of rotenone-induced PD rat model.

  2013cites this paper
• Naringenin ameliorates Alzheimer's disease (AD)-type neurodegeneration with cognitive impairment (AD-TNDCI) caused by the intracerebroventricular-streptozotocin in rat model.

  2012cites this paper
• What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s research

  2012cites this paper
• Effect of benzothiazole/piperazine derivatives on intracerebroventricular streptozotocin-induced cognitive deficits

  2012cites this paper